pandem
precipit
global
crisi
confirm
case
confirm
death
global
march
present
two
central
public
health
control
strategi
emerg
mitig
suppress
eg
strategi
focu
reduc
new
infect
reduc
interact
rais
question
sustain
longterm
tactic
complementari
approach
develop
analyz
epidemiolog
intervent
model
leverag
serolog
test
identifi
deploy
recov
individu
focal
point
sustain
safer
interact
via
interact
substitut
ie
develop
term
shield
immun
popul
scale
recov
individu
present
context
repres
develop
protect
antibodi
longer
shed
viru
object
shield
immun
strategi
help
sustain
interact
necessari
function
essenti
good
servic
includ
limit
tend
elderli
hospit
care
school
food
suppli
decreas
probabl
transmiss
essenti
interact
show
shield
immun
approach
may
significantli
reduc
length
reduc
overal
burden
outbreak
work
synergist
social
distanc
present
model
highlight
valu
serolog
test
part
intervent
strategi
addit
well
recogn
role
estim
preval
potenti
develop
plasmabas
therapi
absenc
reliabl
pharmaceut
intervent
multipl
public
health
strategi
deploy
slow
coronaviru
pandem
strategi
broadli
group
two
approach
mitig
suppress
mitig
includ
combin
social
distanc
includ
school
univers
closur
case
test
symptomat
case
isol
reduc
epidem
spread
burden
hospit
mitig
intend
lessen
outbreak
howev
level
diseas
may
still
overwhelm
health
servic
instead
jurisdict
either
preemptiv
reactiv
adopt
combin
travel
restrict
shown
effect
curtail
dispers
implement
earli
enough
suppress
impos
complet
shutdown
bulk
nonessenti
servic
extend
period
eg
shelter
place
suppress
led
mark
decreas
preval
short
term
combin
case
isol
quarantin
use
separ
facil
treat
covid
patient
largescal
viral
test
reduc
transmiss
suppress
also
come
signific
cost
threaten
social
order
socioeconom
health
propos
complementari
intervent
approach
intend
reduc
transmiss
lessen
cost
suppress
mitig
core
idea
leverag
mechan
interact
substitut
identifi
deploy
recov
individu
protect
antibodi
intent
develop
populationlevel
shield
immun
amplifi
proport
interact
recov
individu
rel
individu
unknown
statu
see
figur
assum
recov
individu
ie
virusneg
antibodyposit
safe
interact
suscept
infecti
individu
effect
substitut
interact
suscept
infecti
individu
interact
recov
individu
intervent
strategi
local
scope
scale
outbreak
size
given
potenti
impact
shield
immun
grow
local
outbreak
recogn
assumpt
safeti
recov
individu
interact
vital
import
return
issu
discuss
translat
effort
typeset
revt
e
x
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
bottom
individu
view
baselin
scenario
shield
scenario
identif
design
deploy
recov
individu
critic
enabl
sr
ir
interact
replac
si
interact
bond
denot
interact
individu
shield
immun
panel
icon
recov
individu
denot
identif
individu
protect
antibodi
henc
enhanc
contribut
individu
shield
immun
contrast
baselin
panel
shield
immun
illustr
concept
shield
immun
consid
epidem
model
individu
tend
substitut
interact
identifi
strateg
locat
recov
individu
henc
rather
mix
random
consid
rel
prefer
given
individu
interact
recov
individu
would
otherwis
potenti
infecti
interact
dynam
fraction
suscept
infecti
recov
r
individu
recov
convent
sir
model
note
denomin
thought
r
given
r
equival
term
detail
mix
substitut
model
could
lead
variat
model
eg
spatial
explicit
domain
network
etc
figur
illustr
shield
immun
impact
sir
epidem
r
sir
model
shield
immun
reduc
epidem
peak
reduc
epidem
durat
effect
shield
act
neg
feedback
loop
ie
given
effect
reproduct
number
r
ef
f
r
result
interact
substitut
increas
recov
individu
increas
number
identifi
exampl
case
epidem
conclud
less
infect
contrast
final
size
approxim
baselin
scenario
without
shield
next
appli
concept
shield
immun
epidemiolog
dynam
pandem
ignor
birth
caus
death
simplic
consid
popul
suscept
expos
e
infecti
asymptomat
infecti
symptomat
recov
r
free
move
without
restrict
busi
usual
scenario
subset
symptomat
case
requir
hospit
care
divid
subacut
hsub
criticalacut
ie
requir
icu
intervent
hcri
case
assum
sub
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
stantial
fraction
critic
case
die
agestratifi
risk
hospit
acut
case
adapt
imperi
colleg
london
report
full
model
incorpor
shield
immun
see
si
equat
detail
figur
schemat
differ
convent
sir
model
social
distanc
case
isol
intervent
key
way
rate
transmiss
reduc
factor
n
tot
shield
n
tot
denot
fraction
popul
circul
baselin
r
shield
denot
total
number
recov
individu
age
subset
total
recov
popul
model
assum
recov
individu
immun
subset
avail
facilit
interact
substitut
model
assum
circul
pool
interact
hospit
patient
must
incorpor
implement
scenario
healthcar
worker
hcw
repres
intend
target
shield
immun
baselin
epidemiolog
paramet
age
stratifi
risk
popul
structur
list
si
adapt
see
github
code
full
implement
detail
use
baselin
epidemiolog
paramet
seed
outbreak
singl
expos
individu
outbreak
reach
total
preval
eg
individu
infect
popul
point
shield
strategi
implement
outbreak
scenario
differ
transmiss
rate
r
low
high
scenario
respect
earli
estim
r
wuhan
consist
ci
put
high
scenario
conserv
end
estim
rang
howev
r
high
scenario
examin
consist
rang
consid
imperi
colleg
london
group
median
r
ef
f
ci
estim
via
stochast
model
fit
outbreak
data
china
account
undocu
transmiss
moreov
control
measur
reduc
transmiss
low
scenario
consist
estim
r
ef
f
ci
china
jan
feb
travel
restrict
control
measur
impos
figur
show
result
compar
intervent
baselin
case
simpl
sir
model
shield
could
potenti
decreas
epidem
burden
across
multipl
metric
decreas
total
impact
shorten
peak
event
popul
size
high
scenario
final
epidem
predict
death
baselin
case
vs
death
given
intermedi
shield
death
given
enhanc
shield
popul
size
low
scenario
final
epi
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
demic
predict
death
baselin
case
vs
death
given
intermedi
shield
death
given
enhanc
shield
major
death
age
despit
lower
fraction
individu
rang
see
figur
consist
estim
relat
model
outbreak
itali
china
note
simul
result
consid
impact
base
shield
alon
wherea
ongo
restrict
via
social
distanc
shelter
place
order
reduc
interact
rate
point
revisit
later
effect
shield
depend
product
number
potenti
shield
identifi
effect
substitut
ie
combin
identif
interact
rate
shield
populationscal
impact
shield
depend
multipl
factor
includ
demograph
distribut
fraction
asymptomat
transmiss
durat
immun
si
treat
item
length
first
find
popul
strongli
rightshift
demograph
distribut
receiv
potenti
benefit
shield
even
though
fewer
recov
individu
age
draw
rel
sens
impact
shield
immun
greater
find
rel
reduct
death
via
shield
immun
proport
rel
differ
fraction
popul
eg
see
si
detail
usstat
level
analysi
similar
result
hold
countri
like
itali
popul
older
nearli
older
figur
second
shield
immun
robust
variat
asymptomat
infect
probabl
improv
outcom
model
vari
baselin
level
asymptomat
transmiss
see
figur
addit
present
model
result
assum
immun
rel
fast
onset
perman
durat
clinic
work
zhejiang
univers
china
suggest
seroconvers
total
antibodi
ab
igm
igg
antibodi
develop
median
period
day
respect
albeit
symptomat
patient
hospit
similar
data
seroconvers
asymptomat
individu
includ
si
show
impact
shield
immun
robust
insofar
durat
immun
month
longer
figur
note
distinct
control
measur
extend
epidem
would
like
impact
effect
shield
immun
context
titer
protect
antibodi
individu
infect
relat
betacoronavirus
caus
mildmoder
symptom
reduc
one
year
period
reexposur
lead
reinfect
contrast
evid
multiyear
immun
individu
recov
sar
addit
emphas
accuraci
serolog
test
key
benefit
shield
immun
undermin
recov
individu
reinfect
even
littl
danger
potenti
misidentifi
lead
interact
substitut
individu
could
infect
other
risk
reduc
combin
serolog
pcr
thu
far
focus
impact
shield
immun
singular
strategi
yet
practic
multipl
intervent
use
parallel
henc
evalu
synergist
potenti
util
shield
immun
combin
social
distanc
social
distanc
model
reduct
transmiss
rate
sustain
postintervent
period
appar
figur
shield
augment
social
distanc
particularli
social
distanc
rel
ineffect
exampl
contour
line
reduct
total
fatal
suggest
combin
reduct
tran
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
mission
equival
nearli
reduct
transmiss
absenc
shield
immun
howev
tradeoff
social
distanc
reduc
contact
transmiss
fewer
recov
individu
reduc
nonetheless
benefit
shield
accru
level
social
distanc
social
distanc
shield
immun
may
work
combin
improv
outcom
term
expect
hospit
burden
suggest
role
shield
immun
reduc
transmiss
reduc
neg
impact
suppressionlevel
social
distanc
polici
final
note
target
shield
immun
may
also
enhanc
popul
outcom
focus
effort
recov
individu
subset
popul
si
show
heurist
solut
optim
formul
target
ie
agespecif
shield
immun
model
effect
preferenti
target
older
individu
possibl
reduc
cumul
death
see
figur
serolog
test
need
scale
mani
reason
shown
rational
serolog
test
mean
facilit
intervent
beyond
mitig
suppress
identifi
deploy
recov
individu
could
repres
metric
state
epidem
eg
better
measur
preval
denomin
opportun
slow
transmiss
develop
populationlevel
shield
immun
mani
logist
social
dynam
challeng
remain
idea
move
theori
feasibl
accur
rapid
serolog
test
need
scale
includ
target
survey
identifi
essenti
worker
via
populationlevel
survey
potenti
scale
shield
immun
depend
intrins
epidem
dynam
drive
number
recov
individu
abl
provid
shield
immun
also
abil
identifi
deploy
eg
via
shield
paramet
yet
even
test
avail
get
public
health
author
government
agenc
consid
priorit
critic
role
experi
disast
respons
well
prior
individu
test
posit
could
return
serologybas
viral
shed
assay
posit
confirm
immun
cessat
viral
shed
could
help
identifi
deploy
ten
thousand
individu
part
shield
immun
strategi
greatest
concentr
like
coloc
area
greatest
need
intervent
nation
global
strategi
could
consid
deploy
critic
respons
worker
help
control
new
outbreak
recogn
signific
challeng
develop
implement
intervent
aim
develop
populationwid
shield
immun
nonetheless
magnitud
current
public
health
econom
crisi
demand
largescal
action
eg
efficaci
shield
immun
strategi
demograph
testand
contextdepend
beyond
nearterm
durat
immun
memori
also
relev
project
multiyear
postpandem
framework
demograph
dynam
strain
evolut
increasingli
relev
move
forward
critic
understand
shield
immun
modul
spatial
network
structur
network
wellconnect
individu
disproportion
effect
spread
diseas
network
structur
repres
opportun
posit
immun
shield
focal
point
essenti
servic
even
priorit
focu
populationscal
serolog
preval
assay
base
connect
target
individu
although
number
laboratori
confirm
stagger
grow
actual
number
infect
higher
like
far
higher
exampl
china
transmiss
new
case
undocu
infect
signific
uncertainti
respect
case
ascertain
asymptomat
transmiss
may
paradox
provid
greater
pool
recov
individu
develop
shield
immun
scale
contend
time
collect
action
ascertain
inform
preval
consid
strateg
use
serolog
basi
public
health
intervent
slow
pandem
spread
data
avail
simul
code
use
develop
manuscript
avail
http
githubcomweitzgroupcovidshieldimmun
